Jobst Vascular Institute, Toledo, Ohio; First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
Jobst Vascular Institute, Toledo, Ohio.
J Vasc Surg Venous Lymphat Disord. 2020 Nov;8(6):1025-1030. doi: 10.1016/j.jvsv.2020.01.018. Epub 2020 Mar 21.
The Villalta scale (VS) is a recommended and widely used clinical severity score for diagnosis and grading of post-thrombotic syndrome (PTS). However, patients with primary chronic venous disease (CVD) who have a history of deep venous thrombosis (DVT) may be classified as having PTS even though post-thrombotic disease is not actually present. The purpose of this study was to investigate the biases of the VS with use in patients with pre-existing CVD.
This single-center, prospective, observational study included patients who were diagnosed with CVD during a 12-month period from 2016 to 2017. The VS and the Venous Clinical Severity Score (VCSS) were completed, and bilateral lower extremity venous duplex ultrasound studies were performed. The correlation of the VS with the VCSS was analyzed. Sensitivity, specificity, positive bias, and negative bias of the VS combined with a history of DVT were calculated. For patients in whom DVT developed during the study, the VS score was taken 12 months after the onset of DVT and compared with the score before DVT.
A total of 288 patients were included. The VS score correlated well with the VCSS, with a correlation coefficient of 0.86 (P < .001). The two scores changed similarly over time. The accuracy of the VS combined with a history of DVT was 94.1%, with a sensitivity of 71.4% and a specificity of 95.9%. The positive bias was as high as 42.3%, although the negative bias was 2.3%. The VS score decreased to a normal level during follow-up in 41.7% of the CVD patients in whom a new DVT developed (n = 12).
The use of the VS for defining PTS appeared to misclassify those with primary CVD and a history of DVT as having PTS by 42.3%. Using the VS at follow-up in patients with PTS and pre-existing CVD may be misleading. Re-evaluation of the results of previous studies that used the VS may be needed.
Villalta 量表(VS)是一种推荐使用的临床严重程度评分标准,用于诊断和分级血栓后综合征(PTS)。然而,患有原发性慢性静脉疾病(CVD)且有深静脉血栓形成(DVT)病史的患者可能被归类为 PTS,尽管实际上不存在血栓后疾病。本研究的目的是研究 VS 在患有预先存在 CVD 的患者中的应用偏差。
这是一项单中心、前瞻性、观察性研究,纳入了 2016 年至 2017 年期间被诊断为 CVD 的患者。完成 VS 和静脉临床严重程度评分(VCSS),并进行双侧下肢静脉双功能超声检查。分析 VS 与 VCSS 的相关性。计算 VS 结合 DVT 病史的敏感性、特异性、阳性偏倚和阴性偏倚。对于在研究期间发生 DVT 的患者,在 DVT 发病后 12 个月测量 VS 评分,并与 DVT 前的评分进行比较。
共纳入 288 例患者。VS 评分与 VCSS 相关性良好,相关系数为 0.86(P<0.001)。两个评分随时间变化相似。VS 结合 DVT 病史的准确性为 94.1%,敏感性为 71.4%,特异性为 95.9%。阳性偏倚高达 42.3%,尽管阴性偏倚为 2.3%。在新发生 DVT 的 CVD 患者中(n=12),41.7%的患者 VS 评分在随访中降至正常水平。
使用 VS 定义 PTS 似乎会错误地将原发性 CVD 和 DVT 病史的患者归类为 PTS,其错误率为 42.3%。在 PTS 和预先存在的 CVD 患者中使用 VS 进行随访可能会产生误导。可能需要重新评估以前使用 VS 的研究结果。